Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 制造业
Company Introduction 上海神奇制药投资管理股份有限公司（公司简称：神奇制药）是一家医药制造类控股型投资公司，是专业从事抗肿瘤、心脑血管、感冒止咳、儿童用药和抗真菌等类药品的研发、生产和销售的企业。公司为上海证券交易所A、B股上市公司（股票代码：A股：600613；B股：900904）。目前，公司注册资本为53,407.16万元，总资产30多亿元。 公司“神奇”品牌有超过30多年的经营历史，2002年被国家工商总局评定为“中国驰名商标”，2004年至2014年连续11年登上世界品牌实验室中国500强最具价值品牌排行榜。2015年1月12日神奇制药荣登“2015福布斯中国上市潜力企业100强”桂冠，2012至2023连续11年荣获中国医药最具影响力“中国制造100强”、“中国医药行业成长50强”。公司在全国已形成了“神奇国药、贵在疗效”的品牌文化、品牌知名度、美誉度和影响力。神奇制药现有贵阳、黔南等11个生产基地，占地面积合计约1600余亩，共拥有10多种剂型，50余条生产线，均已通过了国家合规性检查。 神奇制药正在贵阳国家高新技术开发区投资建设新厂区，占地300亩。其中一期建设已建成投入使用，神奇制药将竭力把新厂区打造为高效经济、绿色环保、人本科技、可持续发展的现代化医药科技产业园。 神奇制药秉承“通过持续创新，致力于为民众健康提供高品质的产品和服务”的使命，始终坚持以“质量为神、疗效必奇”的企业生产质量方针；同时公司还与国内外著名药物研究机构建立了长期的合作关系，现已开发独立知识产权的民族药14个，国家发明专利数十件，2021年抗肿瘤系列产品《斑蝥酸钠原料药及制剂的技术开发及应用》项目获得贵州省科技进步一等奖，企业的研发和技术创新能力得到了社会认同。 公司的产品兼具处方药和OTC品种，主要在销品种有独家专利抗肿瘤用药、皮肤外用抗菌系列、三高慢病产品系列、经典感冒止咳系列、经典滋补产品系列、苗药强筋健骨系列、神奇娃娃儿药系列、其他特色产品系列等八大领域产品，141个国药准字号产品，在全国31个省（市、自治区）100多个地级以上城市销售。 神奇制药在发展壮大的同时，始终保持着强烈的社会责任感，不忘回报社会。先后捐资2亿多元在贵州铺路架桥、精准扶助贫困地区农民发展、修建中小学校，并出资在北京中医药大学、沈阳药科大学和贵州民族学院设立“贫困学生助学金”，帮助贫困学生完成学业。2002年3月实施“光彩康复工程”，通过国家卫生部向非洲及西部12个贫困县无偿提供1.2亿元的抗结核药品帕司烟肼片（原结核康欣片）。2020年在抗击“新冠“疫情期间荣获”抗疫慈善爱心企业“称号。
Main Business 药品的研发、生产与销售，产品涉及抗肿瘤、感冒止咳、心脑血管、风湿骨痛、抗真菌、补益安神及妇科等治疗领域。
Legal Representative 张涛涛
Top Executives
董事长：张涛涛
副董事长：张芝庭
董事：张芝庭,冯斌,徐丹,陈之勉,吴涛
独立董事：段竞晖,李丛艳,陈世贵
Top 5 Shareholder
Shareholder name Nature Holding Date
贵州神奇控股（集团）有限公司流通A股16.98%30/09/2024
贵州迈吉斯投资管理有限公司流通A股16.48%30/09/2024
杭州雀石私募基金管理有限公司－雀石知几2号私募证券投资基金流通A股5.62%30/09/2024
张之君流通A股5.00%30/09/2024
文邦英流通A股4.53%30/09/2024
Company Secretary 吴克兢
Solicitors 北京市中伦律师事务所
Auditors 立信会计师事务所（特殊普通合伙）
Tel No 021－53750009
Fax No 021－53750010
Website www.gzsq.com
Email shanghaiys@126.com
Company Address
Register: 上海市浦东新区上川路995号
Office: 上海市威海路128号长发大厦613室
Listing Date 20/08/1992
Shares Capital
Shares Capital: 534,071,628
Total A Share: 479,319,978
Listed A Share: 479,319,978
Non-tradable A Share: 0
Other Share: 0
Total B Share: 54,751,650
Total H Share: 0
EPS(RMB)* ¥ 0.110
DPS(RMB)* ¥ 0.100
NBV Per Share(RMB)* ¥ 4.373
Market Capitalization(RMB) 3.724B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.